91 related articles for article (PubMed ID: 1652045)
1. Pharmacological studies in animals of beta-hydroxyethyltheophylline, the major metabolite of doxofylline in humans.
Franzone JS; Cirillo R; Reboani MC
Methods Find Exp Clin Pharmacol; 1991 May; 13(4):289-99. PubMed ID: 1652045
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological and toxicological activities of a new methylxanthine derivative [7-(1,3-dithiolan-2-ylmethyl)1,3-dimethylxanthine] with antibronchospastic and mucoregulatory properties.
Franzone JS; Reboani MC; Biglione V; Cirillo R
Drugs Exp Clin Res; 1990; 16(6):263-76. PubMed ID: 1964891
[TBL] [Abstract][Full Text] [Related]
3. Doxofylline and theophylline are xanthines with partly different mechanisms of action in animals.
Franzone JS; Cirillo R; Barone D
Drugs Exp Clin Res; 1988; 14(7):479-89. PubMed ID: 3240706
[TBL] [Abstract][Full Text] [Related]
4. Doxofylline, an antiasthmatic drug lacking affinity for adenosine receptors.
Cirillo R; Barone D; Franzone JS
Arch Int Pharmacodyn Ther; 1988; 295():221-37. PubMed ID: 3245738
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological and toxicological studies of an original xanthine derivative with bronchodilatating activity.
Staneva D; Chakurova L; Ivanova N; Spasov V; Raynova L; Bogoslovova T
Acta Physiol Pharmacol Bulg; 1984; 10(4):44-52. PubMed ID: 6535369
[TBL] [Abstract][Full Text] [Related]
6. Pharmacodynamic profile of isbufylline, a new antibronchospastic xanthine devoid of central excitatory actions.
Manzini S; Meini S; Giachetti A; Beani L; Borea PA; Antonelli T; Ballati L; Bacciarelli C
Arzneimittelforschung; 1990 Nov; 40(11):1205-13. PubMed ID: 1707621
[TBL] [Abstract][Full Text] [Related]
7. Doxofylline differs from methylxanthines in its movement of cytosolic calcium.
Franzone JS; Cirillo R; Reboani MC
Int J Tissue React; 1991; 13(3):131-8. PubMed ID: 1960014
[TBL] [Abstract][Full Text] [Related]
8. Pharmacological researches on 2-(7'-theophyllinemethyl)1,3-dioxolane.
Franzone JS; Reboani C; Fonzo D; Di Carlo R
Farmaco Sci; 1981 Mar; 36(3):201-19. PubMed ID: 6262105
[TBL] [Abstract][Full Text] [Related]
9. Pharmacological properties of a new antiasthmatic xanthine derivative devoid of central stimulatory activity.
Duhault J; Boulanger M; Lonchampt M; Tisserand F; Holstorp S; Saint-Romas G; Pennel L; Regnier G
Arzneimittelforschung; 1987 Dec; 37(12):1353-62. PubMed ID: 2835053
[TBL] [Abstract][Full Text] [Related]
10. Experimental studies on the antitussive properties of the new xanthine derivative 1H-purine-2,6-dione, 3,7-dihydro-3-methyl-7[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]. 2nd communication: investigations on theophylline-like activities.
Mikus EG; Kapui Z; Korbonits D; Boér K; Boronkay E; Gyürky J; Révész J; Lacheretz F; Pascal M; Arányi P
Arzneimittelforschung; 1997 Dec; 47(12):1358-63. PubMed ID: 9450164
[TBL] [Abstract][Full Text] [Related]
11. Doxofylline, an adenosine-nonblocking xanthine, does not induce cardiostimulant effects.
Cirillo R; Grossi E; Franzone JS
Res Commun Chem Pathol Pharmacol; 1989 Jul; 65(1):21-34. PubMed ID: 2781149
[TBL] [Abstract][Full Text] [Related]
12. Doxofylline in rat brain in relation to locomotor activity.
Cravanzola C; Reboani MC; Grosa G; Franzone JS
Drug Metab Dispos; 1989; 17(4):437-40. PubMed ID: 2571486
[TBL] [Abstract][Full Text] [Related]
13. Chemical and pharmacological properties of some 7-beta-hydroxy-gamma-piperazinopropyl-8-benzylaminotheophylli nes.
Gorczyca M; Pawłowski M; Mrozikiewicz A; Kozłowska T; Wasik A
Pol J Pharmacol Pharm; 1986; 38(1):85-90. PubMed ID: 3763487
[TBL] [Abstract][Full Text] [Related]
14. Bronchodilatory activity and pharmacokinetics of new xanthines in guinea-pigs.
Takagi K; Hasegawa T; Nadai M; Sakai R; Miyamoto K
Clin Exp Pharmacol Physiol; 1992 Jun; 19(6):447-56. PubMed ID: 1318809
[TBL] [Abstract][Full Text] [Related]
15. Antiasthmatic new Japanese molecules: the pharmacological profile of tiaramide hydrochloride.
Kumada S; Ohara K; Motoyama Y; Hirai O; Tomoi M
Allergol Immunopathol (Madr); 1981; Suppl 9():191-9. PubMed ID: 6187196
[No Abstract] [Full Text] [Related]
16. [Selectivity of the action of 1,3-dipropyl-8-phenylxanthine on the purine receptors of the intestines].
Gmiro VE; Komissarov IV; Serdiuk SE; Kharin NA
Farmakol Toksikol; 1988; 51(4):60-2. PubMed ID: 3191974
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodynamic profile of the new potent antibronchospastic agent 7-[(2,2-dimethyl)propyl]-1-methyl xanthine.
Evangelista S; Ballati L; Boni P; Castellucci A; Perretti F; Tramontana M; Toja E
Arzneimittelforschung; 1995 May; 45(5):569-75. PubMed ID: 7612055
[TBL] [Abstract][Full Text] [Related]
18. Studies on tetrahydroisoquinolines (THI). VI. Effects of trimetoquinol on tracheal and some other smooth muscles.
Kiyomoto A; Iwasawa Y; Harigaya S
Arzneimittelforschung; 1970 Jan; 20(1):46-52. PubMed ID: 4392500
[No Abstract] [Full Text] [Related]
19. [Experimental toxicological and pharmacodynamic studies of a triple drug association (adrenaline, atropine and papaverine) with anti-bronchospastic activity].
Lampa E; Rossi F; Rosatti F; Vacca C; Giordano L; Del Vecchio F; Alise G; Di Tonto B
Arch Sci Med (Torino); 1978; 135(3):327-50. PubMed ID: 708086
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological profile of the novel, potent and selective peptide leukotriene antagonist (E)-2,2-diethyl-3'-[2-[2-(4-isopropyl)thiazolyl]ethenyl]succinanilic acid.
Yamada N; Yamada K; Takahashi K; Nakao E; Kadowaki S; Umezu K
Arzneimittelforschung; 1994 Jun; 44(6):749-53. PubMed ID: 8053974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
